Paraherquamide and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in Ascaris muscle.
Paraherquamide is a novel natural anthelmintic product with a mode of action that is incompletely characterized. Nicotine and cholinergic-anthelmintic agonists of different chemical classes were used to produce contraction in Ascaris muscle strips. Paraherquamide and a semisynthetic derivative, 2-deoxy-paraherquamide, antagonized these responses. Analysis of the actions of the antagonists was made using the simple competitive model and nonlinear regression to estimate the pK(B) values of the antagonists. The analysis was tested using Clark plots. The pK(B) values for paraherquamide were: nicotine, 5.86 +/- 0.14; levamisole, 6.61 +/- 0.19; pyrantel, 6.50 +/- 0.11; and bephenium, 6.75 +/- 0.15. The pK(B) of nicotine was significantly different from the pK(B) values for levamisole, pyrantel, and bephenium, showing that paraherquamide can distinguish a subtype of cholinergic receptors sensitive to nicotine and a subtype of cholinergic receptors sensitive to levamisole, pyrantel, and bephenium. The pK(B) values for 2-deoxy-paraherquamide were: levamisole, 5.31 +/- 0.13; pyrantel, 5.63 +/- 0.10; and bephenium, 6.07 +/- 0.13. The Clark plots of the antagonism illustrated the degree of fit to the competitive model for 2-deoxy-paraherquamide. 2-Deoxy-paraherquamide selectively antagonized the effects of bephenium; the pK(B) values of levamisole and pyrantel were significantly different from the pK(B) of bephenium. Paraherquamide and 2-deoxy-paraherquamide are selective competitive cholinergic antagonists that distinguish subtypes of cholinergic receptor in Ascaris muscle corresponding to nicotine-, levamisole-, and bephenium-sensitive receptors.
Department of Biomedical Sciences, Iowa State University, Ames, IA 50011, USA. alanr@iastate.edu
Alan P
AP
Robertson
Cheryl L
CL
Clark
Teresa A
TA
Burns
David P
DP
Thompson
Timothy G
TG
Geary
Sasa M
SM
Trailovic
Richard J
RJ
Martin
D000465:Algorithms; D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology*; D000969:Antinematodal Agents / Q000494:pharmacology; D001200:Ascaris / Q000502:physiology*; D001667:Binding, Competitive / Q000187:drug effects; D004079:Dihydro-beta-Erythroidine / Q000494:pharmacology; D005260:Female; D007212:Indolizines / Q000494:pharmacology*; D007537:Isometric Contraction / Q000187:drug effects; D007978:Levamisole / Q000494:pharmacology; D009132:Muscles / Q000187:drug effects*; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011978:Receptors, Nicotinic / Q000187:drug effects; D013141:Spiro Compounds / Q000494:pharmacology*
C465278:2-deoxyparaherquamide; D000871:Anthelmintics; D000969:Antinematodal Agents; D007212:Indolizines; D011950:Receptors, Cholinergic; D011978:Receptors, Nicotinic; D013141:Spiro Compounds; D004079:Dihydro-beta-Erythroidine; D007978:Levamisole; C063985:paraherquamide